Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schwefel

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The EMBO Journal|February 10, 2023
Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptorVu Thuy Khanh Le-Trilling, Sofia Banchenko, Darius Paydar, et al.
Molecular Cell|June 27, 2025
An NADH-controlled gatekeeper of ATP synthaseFabian Schildhauer, Petra S J Ryl, Simon M Lauer, et al.
Elife|November 26, 2025
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)Constanza Salinas-Rebolledo, Javier Blesa, Guillermo Valenzuela-Nieto, et al.
Scientific Reports|February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Nature Immunology|January 3, 2024
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayAnn Y Park, Michael Leney-Greene, Matthew Lynberg, et al.
Nature Immunology|February 12, 2024
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayAnn Y Park, Michael Leney-Greene, Matthew Lynberg, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The EMBO Journal|February 10, 2023
Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptorVu Thuy Khanh Le-Trilling, Sofia Banchenko, Darius Paydar, et al.
Molecular Cell|June 27, 2025
An NADH-controlled gatekeeper of ATP synthaseFabian Schildhauer, Petra S J Ryl, Simon M Lauer, et al.
Elife|November 26, 2025
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)Constanza Salinas-Rebolledo, Javier Blesa, Guillermo Valenzuela-Nieto, et al.
Scientific Reports|February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Nature Immunology|January 3, 2024
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayAnn Y Park, Michael Leney-Greene, Matthew Lynberg, et al.
Nature Immunology|February 12, 2024
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayAnn Y Park, Michael Leney-Greene, Matthew Lynberg, et al.
Pageof 3